These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 37250026)
21. Corrigendum: Alterations of Gut Microbiota in Cholestatic Infants and Their Correlation With Hepatic Function. Guo C; Li Y; Wang P; Li Y; Qiu C; Li M; Wang D; Zhao R; Li D; Wang Y; Li S; Dai W; Zhang L Front Microbiol; 2020; 11():1599. PubMed ID: 32793140 [TBL] [Abstract][Full Text] [Related]
22. Corrigendum: Deng H; Yang S; Zhang Y; Qian K; Zhang Z; Liu Y; Wang Y; Bai Y; Fan H; Zhao X; Zhi F Front Microbiol; 2019; 10():601. PubMed ID: 31001213 [TBL] [Abstract][Full Text] [Related]
23. Corrigendum: A Review: The Fate of Bacteriocins in the Human Gastro-Intestinal Tract: Do They Cross the Gut-Blood Barrier? Dicks LMT; Dreyer L; Smith C; van Staden AD Front Microbiol; 2018; 9():2938. PubMed ID: 30546355 [TBL] [Abstract][Full Text] [Related]
24. Diet, Perceived Intestinal Well-Being and Compositions of Fecal Microbiota and Short Chain Fatty Acids in Oat-Using Subjects with Celiac Disease or Gluten Sensitivity. Nylund L; Hakkola S; Lahti L; Salminen S; Kalliomäki M; Yang B; Linderborg KM Nutrients; 2020 Aug; 12(9):. PubMed ID: 32854216 [TBL] [Abstract][Full Text] [Related]
25. Human Gut Microbiota and Its Metabolites Impact Immune Responses in COVID-19 and Its Complications. Nagata N; Takeuchi T; Masuoka H; Aoki R; Ishikane M; Iwamoto N; Sugiyama M; Suda W; Nakanishi Y; Terada-Hirashima J; Kimura M; Nishijima T; Inooka H; Miyoshi-Akiyama T; Kojima Y; Shimokawa C; Hisaeda H; Zhang F; Yeoh YK; Ng SC; Uemura N; Itoi T; Mizokami M; Kawai T; Sugiyama H; Ohmagari N; Ohno H Gastroenterology; 2023 Feb; 164(2):272-288. PubMed ID: 36155191 [TBL] [Abstract][Full Text] [Related]
26. Effects of viremia and CD4 recovery on gut "microbiome-immunity" axis in treatment-naïve HIV-1-infected patients undergoing antiretroviral therapy. Russo E; Nannini G; Sterrantino G; Kiros ST; Di Pilato V; Coppi M; Baldi S; Niccolai E; Ricci F; Ramazzotti M; Pallecchi M; Lagi F; Rossolini GM; Bartoloni A; Bartolucci G; Amedei A World J Gastroenterol; 2022 Feb; 28(6):635-652. PubMed ID: 35317423 [TBL] [Abstract][Full Text] [Related]
27. Corrigendum: Exposure to Antibiotics Affects Saponin Immersion-Induced Immune Stimulation and Shift in Microbial Composition in Zebrafish Larvae. López Nadal A; Peggs D; Wiegertjes GF; Brugman S Front Microbiol; 2019; 10():1242. PubMed ID: 31214157 [TBL] [Abstract][Full Text] [Related]
28. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease. Sun MF; Shen YQ Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121 [TBL] [Abstract][Full Text] [Related]
29. The Gut-Liver Axis in Health and Disease: The Role of Gut Microbiota-Derived Signals in Liver Injury and Regeneration. Zheng Z; Wang B Front Immunol; 2021; 12():775526. PubMed ID: 34956204 [TBL] [Abstract][Full Text] [Related]
30. Gut Microbial-Derived Metabolites as Immune Modulators of T Helper 17 and Regulatory T Cells. Calvo-Barreiro L; Zhang L; Abdel-Rahman SA; Naik SP; Gabr M Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675320 [TBL] [Abstract][Full Text] [Related]
31. Effects of the Lipid Metabolites and the Gut Microbiota in ApoE Hu K; Liao XX; Wu XY; Wang R; Hu ZW; Liu SY; He WF; Zhou JJ Front Mol Biosci; 2022; 9():786492. PubMed ID: 35558553 [No Abstract] [Full Text] [Related]
32. Corrigendum: The Role of the Gut Microbiota in the Pathogenesis of Parkinson's Disease. Yang D; Zhao D; Ali Shah SZ; Wu W; Lai M; Zhang X; Li J; Guan Z; Zhao H; Li W; Gao H; Zhou X; Yang L Front Neurol; 2019; 10():1412. PubMed ID: 32116985 [TBL] [Abstract][Full Text] [Related]
33. Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases. Ashique S; De Rubis G; Sirohi E; Mishra N; Rihan M; Garg A; Reyes RJ; Manandhar B; Bhatt S; Jha NK; Singh TG; Gupta G; Singh SK; Chellappan DK; Paudel KR; Hansbro PM; Oliver BG; Dua K Chem Biol Interact; 2022 Dec; 368():110231. PubMed ID: 36288778 [TBL] [Abstract][Full Text] [Related]
34. Gut-liver axis-mediated mechanism of liver cancer: A special focus on the role of gut microbiota. Ohtani N; Hara E Cancer Sci; 2021 Nov; 112(11):4433-4443. PubMed ID: 34533882 [TBL] [Abstract][Full Text] [Related]
35. Gut Microbiota Metabolites in Major Depressive Disorder-Deep Insights into Their Pathophysiological Role and Potential Translational Applications. Ortega MA; Alvarez-Mon MA; García-Montero C; Fraile-Martinez O; Guijarro LG; Lahera G; Monserrat J; Valls P; Mora F; Rodríguez-Jiménez R; Quintero J; Álvarez-Mon M Metabolites; 2022 Jan; 12(1):. PubMed ID: 35050172 [TBL] [Abstract][Full Text] [Related]
36. Functional roles of the microbiota-gut-brain axis in Alzheimer's disease: Implications of gut microbiota-targeted therapy. Zhong SR; Kuang Q; Zhang F; Chen B; Zhong ZG Transl Neurosci; 2021 Jan; 12(1):581-600. PubMed ID: 35070442 [TBL] [Abstract][Full Text] [Related]
37. Corrigendum: Gut microbiome alterations during gastric cancer: evidence assessment of case-control studies. Zhang R; Wu Y; Ju W; Wang S; Liu Y; Zhu H Front Microbiol; 2024; 15():1448265. PubMed ID: 38983629 [TBL] [Abstract][Full Text] [Related]
39. Potential roles of gut microbiota and microbial metabolites in Parkinson's disease. Zheng SY; Li HX; Xu RC; Miao WT; Dai MY; Ding ST; Liu HD Ageing Res Rev; 2021 Aug; 69():101347. PubMed ID: 33905953 [TBL] [Abstract][Full Text] [Related]
40. Possible role of gut microbes and host's immune response in gut-lung homeostasis. Rastogi S; Mohanty S; Sharma S; Tripathi P Front Immunol; 2022; 13():954339. PubMed ID: 36275735 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]